CVS Health Corporation (NYSE: CVS) reported third quarter 2021 earnings results today. Total revenues increased 10% year-over-year to $73.8 billion. Net income attributable to CVS Health was $1.5 billion, or $1.20 per share, compared to $1.2 billion, or $0.93 per share, in the year-ago period. Adjusted EPS rose 18.7% to $1.97. For the full year […]
CVS Health Corporation (NYSE: CVS) reported third quarter 2021 earnings results today. Total revenues increased 10% year-over-year to $73.8 billion. Net income attributable to CVS Health was $1.5 billion, or $1.20 per share, compared to $1.2 billion, or $0.93 per share, in the year-ago period. Adjusted EPS rose 18.7% to $1.97. For the full year […]
CVS Health Corporation (NYSE: CVS) reported third quarter 2021 earnings results today.
Total revenues increased 10% year-over-year to $73.8 billion.
Net income attributable to CVS Health was $1.5 billion, or $1.20 per share, compared to $1.2 billion, or $0.93 per share, in the year-ago period. Adjusted EPS rose 18.7% to $1.97.
For the full year of 2021, the company expects GAAP EPS of $6.13-6.23 and adjusted EPS of $7.90-8.00.
